MAGEE1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.524000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.683800E-01
Normal-vs-Stage2
3.079700E-02
Normal-vs-Stage3
2.247900E-02
Normal-vs-Stage4
2.208400E-01
Stage1-vs-Stage2
2.490800E-01
Stage1-vs-Stage3
1.761180E-01
Stage1-vs-Stage4
4.294400E-01
Stage2-vs-Stage3
5.023800E-01
Stage2-vs-Stage4
5.684000E-01
Stage3-vs-Stage4
2.290000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.974800E-01
Normal-vs-AfricanAmerican
3.869900E-02
Normal-vs-Asian
1.767570E-02
Caucasian-vs-AfricanAmerican
3.136200E-01
Caucasian-vs-Asian
1.773640E-01
AfricanAmerican-vs-Asian
8.762400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.765430E-01
Normal-vs-Female
3.612000E-01
Male-vs-Female
3.653600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.653000E-01
Normal-vs-Age(41-60Yrs)
5.020600E-01
Normal-vs-Age(61-80Yrs)
8.850300E-02
Normal-vs-Age(81-100Yrs)
1.120510E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.031800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.368600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.865200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.267200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.611700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.412200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.403000E-04
Normal-vs-Daily Drinker
5.146400E-01
Normal-vs-Weekly Drinker
1.307670E-02
Normal-vs-Occasional Drinker
3.681800E-01
Normal-vs-Social Drinker
7.845800E-01
Non Drinker-vs-Daily Drinker
3.697200E-01
Non Drinker-vs-Weekly Drinker
2.826600E-01
Non Drinker-vs-Occasional Drinker
3.730400E-01
Non Drinker-vs-Social Drinker
2.345400E-01
Daily Drinker-vs-Weekly Drinker
6.220400E-01
Daily Drinker-vs-Occasional Drinker
9.167000E-01
Daily Drinker-vs-Social Drinker
6.014800E-01
Weekly Drinker-vs-Occasional Drinker
6.762400E-01
Weekly Drinker-vs-Social Drinker
3.565600E-01
Occasional Drinker-vs-Social Drinker
5.254200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.068200E-01
Normal-vs-Grade 2
3.615600E-01
Normal-vs-Grade 3
3.465000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.717840E-02
Grade 1-vs-Grade 3
1.600130E-02
Grade 1-vs-Grade 4
4.068200E-01
Grade 2-vs-Grade 3
8.411400E-01
Grade 2-vs-Grade 4
3.615600E-01
Grade 3-vs-Grade 4
3.465000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.678200E-03
Normal-vs-NonDiabetic
4.004400E-01
Diabetic-vs-NonDiabetic
6.897700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.169300E-04
Normal-vs-NoPancreatitis
2.542000E-01
Pancreatitis-vs-NoPancreatitis
2.943400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.440800E-01
Normal-vs-N1
4.883800E-02
N0-vs-N1
1.341200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.678210E-01
Normal-vs-TP53-NonMutant
8.544800E-01
TP53-Mutant-vs-TP53-NonMutant
7.60670000000685E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
